Literature DB >> 35112550

Primer of Epidemiology IV. Study designs II: Interventional or experimental designs.

Kavita Singh1, Priti Gupta2, Roopa Shivashankar2.   

Abstract

In this article, we describe experimental study designs and focus on randomized controlled trials. Experimental studies are intervention studies in which the investigator tests a new treatment on a selected group of patients. In a controlled design, the effects of an intervention (new treatment) are measured by comparing the outcome in the experimental group with that in a control group. Experimental studies are similar to cohort studies except that the exposure is a deliberate change (intervention) made by the researcher in one group of participants and it overcomes confounding because the treatment is assigned randomly. Further, we discuss various types of randomization (random sequence allocation) and importance of allocation concealment and blinding for proper assessment of outcomes in randomized trials.

Entities:  

Mesh:

Year:  2021        PMID: 35112550      PMCID: PMC9005330          DOI: 10.25259/NMJI_373_19

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.559


  8 in total

1.  James Lind's Treatise of the Scurvy (1753).

Authors:  M Bartholomew
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

2.  Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.

Authors:  Mohammed K Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A Patel; Roopa Shivashankar; Vamadevan S Ajay; A G Unnikrishnan; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon
Journal:  Ann Intern Med       Date:  2016-07-12       Impact factor: 25.391

3.  Documenting the evidence: the case of scurvy.

Authors:  Iain Milne; Iain Chalmers
Journal:  Bull World Health Organ       Date:  2004-10       Impact factor: 9.408

4.  The FDA's critique of the anturane reinfarction trial.

Authors:  R Temple; G W Pledger
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

5.  Sulfinpyrazone in the prevention of sudden death after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

6.  Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.

Authors:  Simon Thom; Neil Poulter; Jane Field; Anushka Patel; Dorairaj Prabhakaran; Alice Stanton; Diederick E Grobbee; Michiel L Bots; K Srinath Reddy; Raghu Cidambi; Severine Bompoint; Laurent Billot; Anthony Rodgers
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

7.  The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial.

Authors:  Mary Beth Weber; Harish Ranjani; Lisa R Staimez; Ranjit M Anjana; Mohammed K Ali; K M Venkat Narayan; Viswanathan Mohan
Journal:  Diabetes Care       Date:  2016-08-08       Impact factor: 19.112

8.  Task shifting of frontline community health workers for cardiovascular risk reduction: design and rationale of a cluster randomised controlled trial (DISHA study) in India.

Authors:  Panniyammakal Jeemon; Gitanjali Narayanan; Dimple Kondal; Kashvi Kahol; Ashok Bharadwaj; Anil Purty; Prakash Negi; Sulaiman Ladhani; Jyoti Sanghvi; Kuldeep Singh; Deksha Kapoor; Nidhi Sobti; Dorothy Lall; Sathyaprakash Manimunda; Supriya Dwivedi; Gurudyal Toteja; Dorairaj Prabhakaran
Journal:  BMC Public Health       Date:  2016-03-15       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.